Patient care & clinical trials

Addenbrooke’s Hospital is a national and regional centre for many cancer types, including lung cancer treatment at Papworth Hospital. We see around 6,000 new patients each year providing the highest quality clinical care backed up by some of the finest cancer science in the world. The 5 year survival rates for our patients are better than the national average for prostate, oesophageal, pancreatic and breast cancers. Over half of cancer patients in the Cambridge region take part in clinical trials - the highest proportion of patients in trials across the UK.

Cancer treatment and care
The diagnosis, treatment and support for cancer patients is provided by Addenbrooke’s Hospital, where around 90 clinical consultants are members of the Cambridge Cancer Centre.
Early phase trials
Cambridge has the highest proportion of cancer patients taking part in clinical trials. These trials will benefit patients in terms of earlier detection and diagnosis, more effective treatments and improved care.
Early phase trials
Clinical research
Cambridge is the regional referral centre for breast, ovarian, prostate, pancreatic, renal, and lung cancers (at Papworth Hospital). Innovative research by Cambridge scientists is improving patient treatment and care.
Clinical research

Subscribe to Centre News Latest news from the CRUK Cambridge Centre

Professor Greg Hannon
Professor Greg Hannon is to become the next Director of the Cancer Research UK Cambridge Institute.
Cancer Cell journal cover art by Pedro Valica.
New research reveals the immune system’s cancer-killing T cells are more effective in a tumour’s oxygen-starved environment when they have access to growth factor VEGF-A.
Human primary liver cancer-derived organoids as a new tool for disease modeling and drug screening.
Cambridge researchers have created ‘mini liver tumours’ in a dish for the first time, which can be used for testing new cancer drugs.